Sec. 4. Cooperative agreements with the Centers for Disease Control and Prevention
370 words·~2 min read·
/bill/116/hr/3073/ih/section-4A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary, in coordination with the Director of the Centers for Disease Control and Prevention and the heads of other agencies, as appropriate, shall enter into cooperative agreements between the Centers for Disease Control and Prevention and health departments of States, political subdivisions of States, and Indian tribes and tribal organizations, to address Lyme Disease and other tick- and vector-borne diseases, and to support the development and implementation of evidence-based research, interventions, and treatment with respect to— educating and informing the public, based on evidence-based public health research and data, about Lyme Disease and other vector-borne diseases; supporting early detection and diagnosis; supporting prevention; improving treatment; supporting care planning and management for individuals with Lyme disease and other tick- and vector-borne diseases; and supporting other relevant activities identified by the Secretary or the Director of the Centers for Disease Control and Prevention, as appropriate.
To be eligible to enter into a cooperative agreement under this section, an entity described in subsection
(a)shall prepare and submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require, including a plan that describes— how the applicant proposes to develop or expand programs to educate individuals through partnership engagement, workforce development, guidance and support for programmatic efforts, and evaluation with respect to Lyme disease and other tick- or vector-borne diseases, and how the applicant proposes to support other relevant activities identified by the Secretary or the Director of the Centers for Disease Control and Prevention, as appropriate; the manner in which the applicant will coordinate with Federal, tribal, and State programs related to Lyme Disease and other vector-borne diseases, and appropriate State, tribal, and local agencies, as well as other relevant public and private organizations or agencies; and the manner in which the applicant will evaluate the effectiveness of any program carried out under the cooperative agreement. -For the purpose of carrying out this section, there are authorized to be appropriated $20,000,000 for each of fiscal years 2021 through 2026. Amounts appropriated shall be allocated under this section to diseases in a manner that proportionately matches the disease burden of those diseases in the United States, which shall be reassessed and adjusted annually.